Table 1. Baseline characteristics of the enrolled patients.
| Total patients (n = 925) | Men (n = 580) | Women (n = 345) | |
|---|---|---|---|
| Age, (y) | 64.4 (57.3–74.0) | 57.3 (55.4–72.8) | 69.7 (61.9–75.5) |
| Smoking, n (%) | 90 (9.7) | 82 (14.1) | 8 (2.3) |
| DM, n (%) | 300 (32.4) | 209 (36.0) | 91 (26.4) |
| Hypertension, n (%) | 473 (51.1) | 295 (50.9) | 178 (51.6) |
| BMI, (kg/m2) | 23.8 ± 3.4 | 24.0 ± 3.1 | 23.6 ± 3.8 |
| MI, n (%) | 265 (28.6) | 198 (34.1) | 67 (19.4) |
| Stroke, n (%) | 63 (6.8) | 42 (7.2) | 21 (6.1) |
| HbA1c, (%) | 5.6 (5.2–6.2) | 5.6 (5.3–6.4) | 5.6 (5.2–6.0) |
| CRP, (mg/L) | 0.2 (0.1–0.3) | 0.2 (0.1–0.3) | 0.2 (0.1–0.3) |
| eGFR, (ml/min/1.73 m2) | 69.1 (52.4–90.6) | 73.4 (55.8–95.5) | 62.0 (47.9–79.9) |
| TG, (mg/dL) | 121.0 (88.0–167.0) | 126.0 (93.0–172.0) | 111.0 (80.5–147.0) |
| HDL-C, (mg/dL) | 47.0 (39.0–57.0) | 45.0 (37.0–54.0) | 53.0 (43.0–66.0) |
| LDL-C, (mg/dL) | 120.6 (98.0–143.8) | 116.2 (95.8–142.6) | 123.3 (102.6–147.2) |
| Non HDL-C, (mg/dL) | 147.0 (121.0–174.0) | 146.0 (119.0–174.0) | 149.5 (125.0–174.0) |
| maxIMT, (mm) | 0.9 (0.7–1.4) | 0.9 (0.7–1.5) | 0.9 (0.7–1.4) |
| ABI | 1.0 (0.9–1.0) | 1.0 (0.9–1.0) | 1.0 (0.9–1.0) |
| baPWV, (m/sec) | 16.2 (13.9–19.0) | 15.9 (13.6–18.8) | 16.6 (14.7–19.8) |
Data given as mean ± SD, median (IQR) or n (%).
ABI, ankle-brachial index; baPWV, brachial-ankle pulse wave velocity; BMI, body mass index; CRP, C-reactive protein; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; maxIMT, maximum intima-media thickness; LDL-C, low-density lipoprotein cholesterol; MI, history of previous myocardial infarction; stroke, history of stroke; TG, triglyceride.